Basel Medical Group Ltd BMGL

Press Release? About what?

Do not sell…this stock is very bullish…very bullish. We just need volume or more buyers to take out the level 2 wall

Level 2, on the ASK is holding the stock’s price down

$BASEL Medical Group Ltd The ideal price for BMGL stock without short selling influence is estimated at $6.00–$9.50 per share, reflecting its fundamental value, growth from the $375 million contract and Bethesda acquisition, and bullish sentiment from technical indicators. This range assumes no downward pressure from putt options or short sellers, allowing BMGL to trade closer to its recent highs ($7.18–$9.40) Speculative targets of $15–$30 are possible if the Bitcoin acquisition gains traction, but these are less grounded without confirmed execution.

$BASEL Medical Group Ltd the short interest float has changed dramatically….there are no short shares available and the short share interest is over 20%. Something has to give when you are dealing with a small float that is around 2 million. Either they are going to keep the price down or morning margin calls. There are limited shares so if a whale join this stock today…it could go crazy….also I heard that Master Card is still in this stock…whales are interested in this stock….

There’s a good chance the price will go up tomorrow. Bullish technical indicators, recent price movement, and positive feelings are all pointing in that direction. But short-term predictions say there might be a small dip back to $6.01–$6.08. If the price keeps going up, it could reach $10–$20, but that’s just a guess and depends on how many people keep buying.

So, about the dilution, the company raised a cool $9 million when it went public in February 2025. They sold 2,205,000 shares at $4 each. And guess what? Basel Medical Group has been on a roll, expanding its operations and even buying Bethesda Medical Pte. Ltd. to make a bigger splash in the Singapore healthcare scene.

Interesting I see a nice bull flag for tomorrow

Is BMGL financially strong?
Yes, it has solid fundamentals with profitable operations, good liquidity, and strategic growth initiatives.

Low float, 0 short shares available and 15% shorted

Basel Medical Group Ltd. exhibits several signs of financial strength, including positive profitability, strong ROE, decent liquidity, and positive free cash flow. Recent contract wins and the Bethesda Medical acquisition bolster its growth prospects in a high-demand healthcare market